1-4 of 4
Maria L. Chauffaille, MD PhD
Close
Sort by
Journal Articles

Additional Information Offered By Snpa in Myelodysplastic Syndromes with Excess Blasts (MDS-EB) and Future Perspectives

Thiago R Noronha, PharmD, Miguel Mitne-Neto, PhD, Maria L. Chauffaille, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5552.
https://doi.org/10.1182/blood.V128.22.5552.5552
Published: 2016
Journal Articles

Leukocytosis Can Predict Thrombotic Events in Myelofibrosis

Laura Coutinho Vassalli, MD, Emilia Carolina Malafaia, MD, Maria L. Chauffaille, MD PhD, Daniella Kerbauy, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5191.
https://doi.org/10.1182/blood.V126.23.5191.5191
Published: 2015
Journal Articles

PI3K/AKT Pathway as a Potential Therapeutic Target In Myelodysplastic Syndrome

Denise C Rezende, PhD, Lorena Zaida Pacheco, master, Luis Arthur F. Pelloso, MD, PhD, Maria L. Chauffaille, MD, PhD, Marçal C.A Silva, MD, Elisa Kimura, Rafael L Casaes-Rodrigues, master, Helena Segreto, MD, PhD, Mihoko Yamamoto, MD, PhD, Daniella Marcia Maranhao Bahia Kerbauy, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1871.
https://doi.org/10.1182/blood.V116.21.1871.1871
Published: 2010
Journal Articles

Acute Promyelocytic Leukemia with T(15;17): Frequency of Additional Clonal Chromosome Abnormalities and FLT3

Maria L. Chauffaille, MD, PhD, Rodrigo Proto Siqueira, PHD, Daniela Borri, MSc, Eloisa S. Moreira, PhD, Fernando L. Alberto, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4857.
https://doi.org/10.1182/blood.V112.11.4857.4857
Published: 2008